The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Open accessAbstract
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Self-citationA SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Menachery, V. D., Yount, B. L., Debbink, K., Agnihothram, S., Gralinski, L. E., Plante, J. A., Graham, R. L., Scobey, T., Ge, X.-Y., Donaldson, E. F., et al. (2015) · Nature Medicine · doi:10.1038/nm.3985 · Cited by 901
Self-citationChan, J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen, K.-Y. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 881
Chan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 608
Li, B., Sedlacek, M., Manoharan, I., Boopathy, R., Duysen, E. G., Masson, P., & Lockridge, O. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.002 · Cited by 540
A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
Ratia, K., Pegan, S., Takayama, J., Sleeman, K., Coughlin, M., Baliji, S., Chaudhuri, R., Fu, W., Prabhakar, B. S., Johnson, M. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805240105 · Cited by 507
Eckerle, L. D., Becker, M. M., Halpin, R. A., Li, K., Venter, E., Lu, X., Scherbakova, S., Graham, R. L., Baric, R. S., Stockwell, T. B., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000896 · Cited by 491
Self-citationSARS-like WIV1-CoV poised for human emergence
Menachery, V. D., Yount, B. L., Sims, A. C., Debbink, K., Agnihothram, S. S., Gralinski, L. E., Graham, R. L., Scobey, T., Plante, J. A., Royal, S. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517719113 · Cited by 418
Self-citationBroad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385
Late Ebola virus relapse causing meningoencephalitis: a case report
Jacobs, M., Rodger, A., Bell, D. J., Bhagani, S., Cropley, I., Filipe, A., Gifford, R. J., Hopkins, S., Hughes, J., Jabeen, F., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30386-5 · Cited by 361
Sims, A. C., Baric, R. S., Yount, B., Burkett, S. E., Collins, P. L., & Pickles, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15511-15524.2005 · Cited by 349
Self-citationMüller, M. A., Meyer, B., Corman, V. M., Al-Masri, M., Turkestani, A., Ritz, D., Sieberg, A., Aldabbagh, S., Bosch, B.-J., Lattwein, E., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70090-3 · Cited by 317
Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
Gralinski, L. E., Bankhead, A., Jeng, S., Menachery, V. D., Proll, S., Belisle, S. E., Matzke, M., Webb-Robertson, B.-J. M., Luna, M. L., Shukla, A. K., et al. (2013) · mBio · doi:10.1128/mbio.00271-13 · Cited by 310
Self-citationHIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
Yamamoto, N., Yang, R., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.083 · Cited by 306
Nguyen, N. M., Tran, C. N. B., Phung, L. K., Duong, K. T. H., Huynh, H. L. A., Farrar, J., Nguyen, Q. T. H., Tran, H. T., Nguyen, C. V. V., Merson, L., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis470 · Cited by 293
Scobey, T., Yount, B. L., Sims, A. C., Donaldson, E. F., Agnihothram, S. S., Menachery, V. D., Graham, R. L., Swanstrom, J., Bove, P. F., Kim, J. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311542110 · Cited by 283
Self-citationInhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Falzarano, D., de Wit, E., Martellaro, C., Callison, J., Munster, V. J., & Feldmann, H. (2013) · Scientific Reports · doi:10.1038/srep01686 · Cited by 273
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice
Becker, M. M., Graham, R. L., Donaldson, E. F., Rockx, B., Sims, A. C., Sheahan, T., Pickles, R. J., Corti, D., Johnston, R. E., Baric, R. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808116105 · Cited by 264
Self-citationViral Load Kinetics of MERS Coronavirus Infection
Oh, M.-D., Park, W. B., Choe, P. G., Choi, S.-J., Kim, J.-I., Chae, J., Park, S. S., Kim, E.-C., Oh, H. S., Kim, E. J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1511695 · Cited by 223
Morgenstern, B., Michaelis, M., Baer, P. C., Doerr, H. W., & Cinatl, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.128 · Cited by 214
Hart, B. J., Dyall, J., Postnikova, E., Zhou, H., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Frieman, M. B., Holbrook, M. R., Jahrling, P. B., et al. (2014) · Journal of General Virology · doi:10.1099/vir.0.061911-0 · Cited by 211
A mouse model for MERS coronavirus-induced acute respiratory distress syndrome
Cockrell, A. S., Yount, B. L., Scobey, T., Jensen, K., Douglas, M., Beall, A., Tang, X.-C., Marasco, W. A., Heise, M. T., & Baric, R. S. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.226 · Cited by 206
Self-citationRisk Factors for Severe Illness with 2009 Pandemic Influenza A (H1N1) Virus Infection in China
Yu, H., Feng, Z., Uyeki, T. M., Liao, Q., Zhou, L., Feng, L., Ye, M., Xiang, N., Huai, Y., Yuan, Y., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq144 · Cited by 175
Sims, A. C., Tilton, S. C., Menachery, V. D., Gralinski, L. E., Schäfer, A., Matzke, M. M., Webb-Robertson, B.-J. M., Chang, J., Luna, M. L., Long, C. E., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02520-12 · Cited by 158
Self-citationBarnard, D. L., Day, C. W., Bailey, K. W., Heiner, M., Montgomery, R. A., Lauridsen, L., Winslow, S. G., Hoopes, J. D., Li, J. K.-K., Lee, J., et al. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.03.001 · Cited by 107
Systematic Assembly of a Full-Length Infectious Clone of Human Coronavirus NL63
Donaldson, E., Yount, B. L., Sims, A. M., Burkett, S. E., Pickles, R. J., & Baric, R. S. (2008) · Journal of Virology · doi:10.1128/jvi.01804-08 · Cited by 103
Self-citationNew Metrics for Evaluating Viral Respiratory Pathogenesis
Menachery, V. D., Gralinski, L. E., Baric, R. S., & Ferris, M. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131451 · Cited by 67
Self-citationA Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant
Agnihothram, S., Yount, B. L., Donaldson, E., Huynh, J., Menachery, V. D., Gralinski, L. E., Graham, R. L., Becker, M. M., Tomar, S., Scobey, T., et al. (2014) · mBio · doi:10.1128/mbio.00047-14 · Cited by 56
Self-citation
Cited by
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
“There were 60 trial sites and 13 subsites in the United States (45 sites), Denmark (8), the United Kingdom (5), Greece (4), Germany (3), Korea (2), Mexico (2), Spain (2), Japan (1), and Singapore (1).”
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
Coronavirus biology and replication: implications for SARS-CoV-2
V’kovski, P., Kratzel, A., Steiner, S., Stalder, H., & Thiel, V. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00468-6 · Cited by 3,197
Metadata
- Authors
- Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., Bannister, R., Park, Y., Babusis, D., Clarke, M. O., Mackman, R. L., Spahn, J. E., Palmiotti, C. A., Siegel, D., Ray, A. S., Cihlar, T., Jordan, R., Denison, M. R., & Baric, R. S.
- Venue
- Science Translational Medicine
- Published
- 2017-06-28
- Volume
- 9
- Issue
- 396
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2725497285
- Cited by
- 1,571
- References
- 31
- FWCI
- 139.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.